Gencurix Inc. (229000.KQ)

KRW 1446.0

(-0.69%)

Operating Expenses Summary of Gencurix Inc.

Gencurix Inc.'s latest annual operating expenses in 2023 was 12.79 Billion KRW , up 3.41% from previous year.
Gencurix Inc.'s latest quarterly operating expenses in 2024 Q2 was 3.04 Billion KRW , down -6.44% from previous quarter.
Gencurix Inc. reported a annual operating expenses of 12.37 Billion KRW in annual operating expenses 2022, up 30.69% from previous year.
Gencurix Inc. reported a annual operating expenses of 9.46 Billion KRW in annual operating expenses 2021, up 19.68% from previous year.
Gencurix Inc. reported a quarterly operating expenses of 3.04 Billion KRW for 2024 Q2, down -6.44% from previous quarter.
Gencurix Inc. reported a quarterly operating expenses of 3.17 Billion KRW for 2023 Q1, down -13.52% from previous quarter.

Annual Operating Expenses Chart of Gencurix Inc. (2023 - 2015)

Historical Annual Operating Expenses of Gencurix Inc. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	12.79 Billion KRW	3.41%
2022	12.37 Billion KRW	30.69%
2021	9.46 Billion KRW	19.68%
2020	7.91 Billion KRW	38.82%
2019	5.69 Billion KRW	7.35%
2018	5.3 Billion KRW	-8.53%
2017	5.8 Billion KRW	-23.11%
2016	7.54 Billion KRW	114.31%
2015	3.52 Billion KRW	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	3.3 Billion KRW	8.14%
2024 Q2	3.04 Billion KRW	-6.44%
2023 Q1	3.17 Billion KRW	-13.52%
2023 Q3	2.96 Billion KRW	-17.69%
2023 Q4	3.06 Billion KRW	3.31%
2023 Q2	3.59 Billion KRW	13.36%
2023 FY	12.79 Billion KRW	3.41%
2022 Q2	3.33 Billion KRW	40.77%
2022 FY	12.37 Billion KRW	30.69%
2022 Q4	3.67 Billion KRW	33.3%
2022 Q3	2.75 Billion KRW	-17.47%
2022 Q1	2.37 Billion KRW	-17.44%
2021 FY	9.46 Billion KRW	19.68%
2021 Q2	2.2 Billion KRW	5.26%
2021 Q3	2.3 Billion KRW	4.43%
2021 Q4	2.87 Billion KRW	24.77%
2021 Q1	2.09 Billion KRW	-94.39%
2020 Q1	3.03 Billion KRW	-35.83%
2020 FY	7.91 Billion KRW	38.82%
2020 Q4	37.35 Billion KRW	4319.03%
2020 Q3	845.27 Million KRW	10.72%
2020 Q2	763.44 Million KRW	-74.87%
2019 FY	5.69 Billion KRW	7.35%
2019 Q4	4.73 Billion KRW	190.02%
2019 Q3	1.63 Billion KRW	0.0%
2018 FY	5.3 Billion KRW	-8.53%
2017 FY	5.8 Billion KRW	-23.11%
2016 FY	7.54 Billion KRW	114.31%
2015 FY	3.52 Billion KRW	0.0%

Peer Operating Expenses Comparison of Gencurix Inc.

Name	Operating Expenses	Operating Expenses Difference
Osang Healthcare Co.,Ltd	78.35 Billion KRW	83.667%
InBody Co.,Ltd	87.36 Billion KRW	85.351%
Curexo Inc.	18.16 Billion KRW	29.538%
Seegene, Inc.	210.08 Billion KRW	93.908%
i-SENS, Inc.	91.12 Billion KRW	85.956%
Ray Co., Ltd.	59.03 Billion KRW	78.32%
Sugentech Inc.	18.6 Billion KRW	31.206%
L&C Bio Co., Ltd	25.86 Billion KRW	50.511%